Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years)
A few weeks ago, Kelly experienced severe hypoglycemia (she left her RileyLink in her basement by accident!) – lucky for her, she had just picked up a new emergency...
FDA approval the fast-acting insulin for children means that children will have more flexibility in their mealtime insulin dosing
Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo
JDRF and Beyond Type 1 are teaming up to support the type 1 community through education, programs, and advocacy
Approved in the US in 2018, the system stops insulin delivery when low blood sugar is predicted
The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no...
Adam’s presentation at Friends for Life 2019
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes
When first diagnosed, Renza was told to fear diabetes complications. This clouded her ability to do even the most basic of self-management
A trial in Boston is enrolling 168 individuals ages 65 years and older with type 1 diabetes to investigate the combination of CGM and education to reduce hypoglycemia
FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...
Nine industry leaders share insights on better diabetes outcomes at lower costs – The diaTribe Foundation’s 4 th annual Musings Under the Moon
By Kerri Sparling Leer este artículo en español. When the ability to share my CGM data came to fruition, I was excited. And nervous. Chris and I talked briefly about...
A collaboration between JDRF, Stanford, and UCSF aims to cure type 1 diabetes through understanding of stem cells and the immune system
The first ever “Closed Loop Showcase”; Ascensia’s diabetes coaching and bundled program; excitement for UnderMyFork app
The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable...
As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...
Diabetes advocates, Renza and Grumpy, share the importance of #LanguageMatters and the consequences of “grading” diabetes management

Pages